JAK Signaling in Depression

NCT07003997 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Baricitinib
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]